$19.01+0.26|(+1.39%)
52W H: 24.59552W L: 10.92Beta: 15.50

About Shoulder Innovations Inc

Frequently Asked Questions

What is the 52-week range for SI?

The 52-week high is $24.595 and the 52-week low is $10.92.

What is the P/E ratio for SI?

The P/E ratio data is currently unavailable.

What is the dividend yield for SI?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -5.06%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 3.77%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.09.

Analyst Recommendation Trends

Wall Street analyst consensus for SI over the last few months:

2026-09-01
Buy: 6
S.Buy: 5
Hold: 1
Sell: 0
2026-08-01
Buy: 6
S.Buy: 5
Hold: 1
Sell: 0
2026-07-01
Buy: 6
S.Buy: 5
Hold: 1
Sell: 0
2026-06-01
Buy: 6
S.Buy: 5
Hold: 1
Sell: 0

Latest SI News

Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Shoulder Innovations, Inc. (SI) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 3:20 PM EDTCompany ParticipantsRobert Ball -...

SeekingAlpha9/16/2026

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company also announced the product's full commercial launch.

Yahoo9/10/2026

Shoulder Innovations Receives FDA Clearance For Its N-22 Humeral Head

Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market,

Benzinga9/10/2026

Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures

Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances f

Yahoo9/9/2026

Shoulder Innovations Enters Into Exclusive Collaboration With ALM Ortho For Bespoke Shoulder Implant; Financial Terms Remain Confidential

Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today

Benzinga9/9/2026

Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience

Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. ("Catalyst") to resolve all outstanding patent litigation between the two companies. The terms of the settlement agreement are confidential.

Yahoo9/8/2026

Shoulder Innovations Enters Into A Settlement Agreement With Catalyst Orthoscience To Resolve All Outstanding Patent Litigation Between The Two Companies

Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has

Benzinga9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to SI:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-14Ball Robert Joseph-89,233--
2026-09-14Ball Robert Joseph-10,175$18.4478$187,706
2026-09-14Ball Robert Joseph+89,233$2.0988$187,282
2026-08-26Gilde Healthcare Holding B.V.-1,196$22.6$27,030
2026-08-24Gilde Healthcare Holding B.V.-681$22.62$15,404
2026-08-21Gilde Healthcare Holding B.V.-20,516$22.61$463,867
2026-08-20Gilde Healthcare Holding B.V.-3,900$22.6$88,140
2026-08-18Ahearn Matthew Fraser-1,600$21.3819$34,211
2026-08-18Ahearn Matthew Fraser-12,586$20.9354$263,493
2026-08-17Ahearn Matthew Fraser-8,314$20.0988$167,101
2026-08-14Ahearn Matthew Fraser-2,500--
2026-08-06Gilde Healthcare Holding B.V.-2,095$22.6$47,347
2026-08-05Gilde Healthcare Holding B.V.-7,338$22.64$166,132
2026-08-04Gilde Healthcare Holding B.V.-99,812$22.77$2,272,719
2026-08-03Gilde Healthcare Holding B.V.-10,751$22.71$244,155
2026-07-31Gilde Healthcare Holding B.V.-20,034$22.73$455,373
2026-07-30Gilde Healthcare Holding B.V.-28,245$23.36$659,803
2026-06-15Ahearn Matthew Fraser-2,500$19.2592$48,148
2026-06-15Ahearn Matthew Fraser-1,644$18.2005$29,922
2026-06-12Ahearn Matthew Fraser-15,856$18.6797$296,185
2026-04-30Ball Robert Joseph-10,000--
2026-04-30Ball Robert Joseph+10,000$2.4804$24,804
2026-04-20Ahearn Matthew Fraser-14,243--
2026-04-20Ahearn Matthew Fraser-7,421--
2026-04-20Ahearn Matthew Fraser+14,243$2.862$40,763
2026-04-20Ahearn Matthew Fraser+7,421$2.4804$18,407
2026-03-13Ball Robert Joseph+2,200$15.1782$33,392
2026-03-13Buchholz Richard+1,000$14.84$14,840
2026-03-13Points Jeffrey S.-13,264--
2026-03-13Points Jeffrey S.+2,000$15$30,000
2026-03-13Points Jeffrey S.+13,264$2.4804$32,900
2026-03-13BUCKMAN PAUL-26,205--
2026-03-13BUCKMAN PAUL-19,401--
2026-03-13BUCKMAN PAUL-3,714$14.82$55,041
2026-03-13BUCKMAN PAUL-3,292$14.62$48,129
2026-03-13BUCKMAN PAUL+26,205$2.0988$54,999
2026-03-13BUCKMAN PAUL+19,401$2.4804$48,122
2026-02-06Ball Robert Joseph-2,062--
2026-02-06Ball Robert Joseph-10,000--
2026-02-06Ball Robert Joseph+2,062$2.0988$4,328
2026-02-06Ball Robert Joseph+10,000$2.4804$24,804
2026-01-30Blue David Lawrence+88,450--
2026-01-30Ball Robert Joseph+265,351--
2026-01-30Ahearn Matthew Fraser+88,450--
2026-01-30Points Jeffrey S.+126,357--
2025-12-31Blue David Lawrence+1,041$12.16$12,659
2025-12-31Ball Robert Joseph+1,661$12.16$20,198
2025-12-31Ahearn Matthew Fraser+477$12.16$5,800
2025-12-31Points Jeffrey S.+1,076$12.16$13,084
2025-12-12Points Jeffrey S.+1,005$14.98$15,055
2025-12-12Ball Robert Joseph+3,900$14.8911$58,075
2025-12-11Points Jeffrey S.+995$14.65$14,577
2025-12-11Ball Robert Joseph+3,300$14.8285$48,934